TG Therapeutics Inc
(STU:NKB2)
€
41.2
-1.5 (-3.51%)
Market Cap: 6.37 Bil
Enterprise Value: 6.54 Bil
PE Ratio: 18.07
PB Ratio: 12.55
GF Score: 78/100 TG Therapeutics Inc (STU:NKB2) Transcripts
- 1